Calcilytix
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.calcilytix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Calcilytix
BridgeBio Pharma is dedicated to improving the lives of individuals with Autosomal Dominant Hypocalcemia Type 1 (ADH1) through the development of Encaleret, an investigational oral treatment targeting calcium-sensing receptor gene. ADH1 is a common genetic condition characterized by hypoparathyroidism caused by gain-of-function variants in the CASR. Encaleret is being developed in partnership with BridgeBio affiliate Calcilytix Therapeutics, aiming to address the physiological imbalances associated with ADH1.Explore more
Calcilytix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Calcilytix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Calcilytix is spiking on competitors!
Product Launch: Get notified when Calcilytix launches new products
Earning: See what the market has to say on Calcilytix recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Calcilytix
Funding: Get notified immidiatlly once Calcilytix has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Calcilytix has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Calcilytix had a recent Job posting/layoffs
Calcilytix, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Calcilytix as Masked Content
Find 2 more new buyers
Compare Similar Companies to Calcilytix
Compare insights from companies similar to Calcilytix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Calcilytix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Calcilytix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Calcilytix.
Calcilytix Tech Stack
A closer look at the technologies used by Calcilytix
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Calcilytix
Sign Up For FreeTo access detailed company insights
BridgeBio Pharma is dedicated to improving the lives of individuals with Autosomal Dominant Hypocalcemia Type 1 (ADH1) through the development of Encaleret, an investigational oral treatment targeting calcium-sensing receptor gene. ADH1 is a common genetic condition characterized by hypoparathyroidism caused by gain-of-function variants in the CASR... Read More
